EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Upright proton therapy for esthesioneuroblastoma: a single-institution experience

Konstantin Gordon, Igor Gulidov, Daniil Smyk, Alexey Semenov, Kirill Golubev, Alyona Lemaeva, Sergey Koryakin, Enar Jumaniyazova, Polina Vishnyakova, Irina Eremina, Timur Fatkhudinov, Andrey Kaprin

Frontiers in Oncology · 30.01.2024 · 14

DOI: 10.3389/fonc.2024.1348291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 30.01.2024. Verfasst von Konstantin Gordon und 11 weiteren Autor:innen. Beteiligte Einrichtung: Proton Therapy Department, A. Tsyb Medical Radiological Research Center - Branch of the National Medical Radiological Research Center, Obninsk, Russi…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education and Science of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study presents an analysis (efficacy and toxicity) of outcomes in patients with esthesioneuroblastoma after pencil beam proton therapy with a fixed beamline in the upright position.

Background

Esthesioneuroblastoma (ENB) is an extremely rare tumor of sinonasal area located in critical proximity to vital structures. Proton therapy (PT) is often considered the optimal radiation treatment for head-and-neck tumors, although of limited availability. Upright PT delivered using fixed pencil beamline and rotating chair is a fairly promising option.

Methods

This is a single-center experience describing the outcomes of PT in 14 patients with ENB treated between January 2016 and October 2022; half of the cases had a history of previous irradiation. The therapy was applied using a fixed pencil beamline with 6D-chair for positioning. The median dose was 63 GyRBE (total range 48–70 GyRBE; based on 1.1 RBE multiplier for protons) with 2.0 GyRBE per fraction. The mean gross tumor volume was 109.5 cm 3 (17.1–257.7 cm 3 ). Patient demography, pathology, treatment parameters and toxicity data were analyzed. Radiation-induced reactions were assessed according to the Common Terminology Criteria for Adverse Events (CTCAE) v 4.0.

Results

The median follow-up time was 28 months. The 1- and 2-year locoregional control rates constituted 100% and 88.9%, respectively; the median duration of local control was 52 months. The 1- and 2-year progression-free survival (PFS) rates constituted 92.9% and 75.0%, respectively; the median PFS duration was 52 months. The 1- and 2-year overall survival (OS) rates constituted 92.9% and 84.4%, respectively. Two patients died of non-cancer-related causes (coronavirus-induced pneumonia) and 1 patient died of tumor progression. All patients tolerated PT well without any treatment gaps. Serious late toxicity reactions included glaucoma in 1 patient and cataract in 2 patients, in over half a year since irradiation.

Conclusion

PT with upright design of the unit affords promising outcomes in terms of disease control and toxicity rates in ENB, a sinonasal tumor of complicated localization.

Schlagwörter

Stichwörter der Autor:innen

brain invasionesthesioneuroblastomaproton therapyradiation therapyreirradiationupright position

Autor:innen und Institutionen

  • Proton Therapy Department, A. Tsyb Medical Radiological Research Center - Branch of the National Medical Radiological Research Center, Obninsk, Russia.
  • Research Institute of Molecular and Cellular Medicine, Medical Institution, P. Lumumba People's Friendship University of Russia, Moscow, Russia.

Förderung

  • Ministry of Education and Science of the Russian Federation

Zitieren

APA

Gordon, K., Gulidov, I., Smyk, D., Semenov, A., Golubev, K., Lemaeva, A., Koryakin, S., Jumaniyazova, E., Vishnyakova, P., Eremina, I., Fatkhudinov, T., & Kaprin, A. (2024). Upright proton therapy for esthesioneuroblastoma: a single-institution experience. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1348291

Vancouver

Gordon K, Gulidov I, Smyk D, Semenov A, Golubev K, Lemaeva A, et al. Upright proton therapy for esthesioneuroblastoma: a single-institution experience. Frontiers in Oncology. 2024;14. doi:10.3389/fonc.2024.1348291

BibTeX
@article{Gordon2024,
  author = {Gordon, Konstantin and Gulidov, Igor and Smyk, Daniil and Semenov, Alexey and Golubev, Kirill and Lemaeva, Alyona and Koryakin, Sergey and Jumaniyazova, Enar and Vishnyakova, Polina and Eremina, Irina and Fatkhudinov, Timur and Kaprin, Andrey},
  title = {Upright proton therapy for esthesioneuroblastoma: a single-institution experience},
  journal = {Frontiers in Oncology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fonc.2024.1348291}
}
Kostenlos starten →